Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3)

Clinical trial NCT00394589 · TERMINATED

Trial details

NCT number: NCT00394589
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2006-03-01
Primary completion: 2008-10-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.